G1 Therapeutics Stock Forecast - Polynomial Regression

GTHXDelisted Stock  USD 7.15  0.00  0.00%   
The Polynomial Regression forecasted value of G1 Therapeutics on the next trading day is expected to be 6.47 with a mean absolute deviation of 0.37 and the sum of the absolute errors of 22.47. GTHX Stock Forecast is based on your current time horizon.
  
G1 Therapeutics polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for G1 Therapeutics as well as the accuracy indicators are determined from the period prices.

G1 Therapeutics Polynomial Regression Price Forecast For the 27th of November

Given 90 days horizon, the Polynomial Regression forecasted value of G1 Therapeutics on the next trading day is expected to be 6.47 with a mean absolute deviation of 0.37, mean absolute percentage error of 0.27, and the sum of the absolute errors of 22.47.
Please note that although there have been many attempts to predict GTHX Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that G1 Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

G1 Therapeutics Stock Forecast Pattern

Backtest G1 TherapeuticsG1 Therapeutics Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of G1 Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent G1 Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.8124
BiasArithmetic mean of the errors None
MADMean absolute deviation0.3684
MAPEMean absolute percentage error0.0734
SAESum of the absolute errors22.4701
A single variable polynomial regression model attempts to put a curve through the G1 Therapeutics historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for G1 Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as G1 Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.967.157.34
Details
Intrinsic
Valuation
LowRealHigh
4.845.037.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as G1 Therapeutics. Your research has to be compared to or analyzed against G1 Therapeutics' peers to derive any actionable benefits. When done correctly, G1 Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in G1 Therapeutics.

View G1 Therapeutics Related Equities

 Risk & Return  Correlation

G1 Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how G1 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading G1 Therapeutics shares will generate the highest return on investment. By undertsting and applying G1 Therapeutics stock market strength indicators, traders can identify G1 Therapeutics entry and exit signals to maximize returns.

G1 Therapeutics Risk Indicators

The analysis of G1 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in G1 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gthx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in GTHX Stock

If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Valuation
Check real value of public entities based on technical and fundamental data